Clinical Trial Update: A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing maribavir to valganciclovir for cytomegalovirus infections in stem cell transplant recipients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Maribavir (maribavir)
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Shire | Conditions: Cytomegalovirus (CMV) | Phase 3 | Status: COMPLETED | Results posted: 2023-03-03